The dietary supplement industry’s leading trade association, the Council for Responsible Nutrition, today announced the addition of four new members: Voting Members — DrVita.com; and Parchem Nutrition Inc.; and Associate Members — Arnold & Porter LLP; and Manatt, Phelps & Phillips, LLP.
Schake will represent L'Oréal USA for all corporate communications and will lead the external communications strategy in the areas of public and media relations, industry and government relations, sustainability and crisis communications.
Bayer HealthCare, makers of the Contour Next portfolio of blood-glucose meters, and dLife Healthcare Solutions, a diabetes behavior change solution, have created and are working together to offer Eat Well, Test Well, a six-week food and nutrition program for people with diabetes available at no charge.
Half a loaf, the saying goes, is better than none. For the generic drug industry, that means that the Supreme Court handed it a partial victory Monday by ruling that “pay for delay” patent settlements between brand name and generic drug companies aren’t necessarily illegal and should be considered on a case-by-case, “rule of reason” approach by the Federal Trade Commission, which staunchly opposes the practice.
Nutrisystem on Thursday announced that in order to meet growing consumer demand for its Nutrisystem D 5-Day Jumpstart Weight Loss Kit, the company has ramped up production and will offer its product in 3,700 Walmart stores by the end of June.
With renewed consumer confidence converting more shoppers into buyers, there is greater opportunity for companies in the health and wellness space, noted a report titled "The Why Behind the Buy Spring 2013," which was released recently by Acosta Sales and Marketing.
Whole Foods Market is celebrating Hemp History Week, which is a nationwide education campaign that runs from June 3 to 9 to raise awareness about the benefits of hemp products, by spotlighting more than 300 hemp products, including body care products.
Retail pharmacists will be missing out on as much as a $20 billion opportunity if they don't identify how to consistently and efficiently engage their patients, suggested Jeff Rehling, principal at Edgewood Consulting Group, during a business session Sunday at the recent 2013 GMDC Health & Wellness @ Retail Conference.
The year is only halfway done, but 2013 is already proving to be a year of particular importance for generic drugs as the industry awaits two important decisions from the Supreme Court and continues to wait for federal biosimilar regulations while fending off efforts to limit the scope of their use at the state level.